Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET

Clinical Nuclear Medicine - United States
doi 10.1097/rlu.0000000000002652
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

O-(2-[18F]fluoroethyl)-L-Tyrosine PET in Gliomas: Influence of Data Processing in Different Centres

EJNMMI Research
Nuclear MedicineRadiologyImaging
2017English

Quantification of O-(2-[18F]fluoroethyl)-L-Tyrosine Kinetics in Glioma

EJNMMI Research
Nuclear MedicineRadiologyImaging
2018English

RESOLUTE PET/MRI Attenuation Correction for O-(2-18f-Fluoroethyl)-L-Tyrosine (FET) in Brain Tumor Patients With Metal Implants

Frontiers in Neuroscience
Neuroscience
2017English

Treatment-Related Uptake of O-(2-[18F]fluoroethyl)-L-Tyrosine and L-[Methyl-3h]-Methionine After Tumor Resection in Rat Glioma Models

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Utilizing 18f-Fluoroethyl-L -Tyrosine Positron Emission Tomography in High Grade Glioma for Radiation Treatment Planning in Patients With Contraindications to MRI

Journal of Medical Imaging and Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2017English

18f-Fet PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non–Small Cell Lung Cancer

Clinical Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2020English

Pseudoprogression Following Chemoradiotherapy for Glioblastoma Multiforme

Canadian Journal of Neurological Sciences
MedicineNeurology
2010English

Detection of Hepatocellular Carcinoma Using 11c-Choline PET: Comparison With 18f-FDG PET

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2008English

Technical Feasibility of [18F]FET and [18F]FAZA PET Guided Radiotherapy in a F98 Glioblastoma Rat Model

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy